论文部分内容阅读
对于恶葡及绒癌的治疗,不管是原发病例或者是转移病例,近年来是以化疗为主,对于恶葡用MTX或ACTD的单独疗法,其缓解率几乎为100%。在绒癌方面用多种药物疗法,可使缓解率有相当提高。在化疗中,MTX特别对本肿瘤是一个有效地药物,作者们对临床诊断为恶葡的病例与过去疗法进行比较,缩短疗程天数,减轻副作用,在此基础上并用CF,MTX一次量增加到原来的4～7倍,关于治疗经过其效果报告如下。
For the treatment of malignant and choriocarcinoma, both the primary case and the metastatic case are chemotherapy-based in recent years. Almost 100% of them are treated with MTX alone or ACTD alone. In choriocarcinoma with a variety of drug therapy, can significantly improve the remission rate. In chemotherapy, MTX is particularly effective in treating this tumor. The authors compared the cases of past diagnosis with those clinically diagnosed as Ebo-treated, shortened the number of days of treatment and reduced side effects. Based on this, MTX was added to the original volume 4 to 7 times, about the effect of treatment through the following report.